Apellis Pharmaceuticals Inc (APLS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 FIFTH AVENUE WALTHAM, MA 02451

Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, the company aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology.

Data as of 2021-09-19 13:11:44 -0400
Market Cap2.976 Billion Shares Outstanding87.003 Million Avg 30-day Volume3.111 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.27 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.37271 52-week High/Low73.0 / 27.5 Next Earnings Date2021-11-02 Price to Cash FLow (P/CF) -23.2109
Data provided by IEX Cloud
View SEC Filings from APLS instead.

View recent insider trading info

Funds Holding APLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

3.8 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

11.3 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WATSON DAVID O. GENERAL COUNSEL

  • Officer
109,193 2021-09-10 9

DUNLOP A. SINCLAIR

  • Director
454,428 2021-09-10 8

CHOPAS JAMES GEORGE SEE REMARKS

  • Officer
0 2021-08-30 2

MACHIELS ALEC

  • Director
809,023 2021-08-16 14

PERRY NICOLE D VICE PRESIDENT - ACCOUNTING

  • Officer
11,008 2021-08-02 12

GROSSI FEDERICO CHIEF MEDICAL OFFICER

  • Officer
62,930 2021-08-02 24

FRANCOIS CEDRIC CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,844,192 2021-07-21 9

DELONG MARK JEFFREY SENIOR VICE PRESIDENT

  • Officer
51,490 2021-07-21 5

DESCHATELETS PASCAL CHIEF SCIENTIFIC OFFICER

  • Officer
1,238,586 2021-06-24 7

SCHEIBLER LUKAS CHIEF INNOVATION OFFICER

  • Officer
26,651 2021-06-10 4

SULLIVAN TIMOTHY EUGENE CHIEF FINANCIAL OFFICER

  • Officer
432,760 2021-06-08 3

BROWN VICTORIA L. PROGRAM TEAM LEAD

  • Officer
9,952 2021-03-25 5

EISELE JEFFREY EXEC VP, PROGRAM TEAM LEAD

  • Officer
14,961 2021-03-01 3

TOWNSEND ADAM J. CHIEF COMMERCIAL OFFICER

  • Officer
18,865 2021-02-10 2

LEWIS KAREN CHIEF PEOPLE OFFICER

  • Officer
6,250 2021-01-28 1

NICHOLSON NUR CHIEF TECHNICAL OFFICER

  • Officer
9,375 2021-01-28 1

CHAN GERALD

  • Director
0 2021-01-01 1

O'BRIEN STEPHANIE MONAGHAN

  • Director
0 2021-01-01 1

FONTEYNE PAUL R.

  • Director
0 2021-01-01 1

CELONA LUCIA SEE REMARKS

  • Officer
5,213 2020-02-10 0

LACKNER THOMAS A. SEE REMARKS

  • Officer
7,725 2020-02-10 0

SADR AHMAD SEE REMARKS

  • Officer
2,725 2020-02-10 0

MORNINGSIDE VENTURE INVESTMENTS LTD

  • 10% Owner
12,556,342 2020-01-13 0

AXON STEVEN CHIEF BUSINESS OFFICER

  • Officer
50,110 2018-11-14 0

GELLERT MICHAEL E

  • 10% Owner
No longer subject to file 2017-11-13 0

HILLHOUSE CAPITAL MANAGEMENT, LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2017-11-13 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2017-11-13 0

AJU IB INVESTMENT CO., LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2017-11-08 0

POTENTIA HOLDINGS, LLC

  • 10% Owner
3,826,601 2017-11-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DUNLOP A. SINCLAIR - Director

2021-09-13 16:10:13 -0400 2021-09-10 M 6,894 $14.00 a 66,894 direct 2.4773 -0.4532 3.3535 4 -0.4532 6

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-09-13 16:08:29 -0400 2021-09-10 M 954 d 0 direct

DUNLOP A. SINCLAIR - Director

2021-09-13 16:10:13 -0400 2021-09-10 M 6,894 d 55,000 direct

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-09-13 16:08:29 -0400 2021-09-10 M 954 $4.31 a 99,193 direct 2.4773 -0.4532 3.3535 4 -0.4532 6

CHOPAS JAMES GEORGE - Officer SEE REMARKS

2021-09-01 16:34:21 -0400 2021-08-30 A 21,750 a 21,750 direct

CHOPAS JAMES GEORGE - Officer SEE REMARKS

2021-09-01 16:34:21 -0400 2021-08-30 A 7,600 a 7,600 direct 2.2517 -44.2191 2.2517 2 -44.2191 6

MACHIELS ALEC - Director

2021-08-17 16:42:44 -0400 2021-08-16 S 2,500 $56.95 d 669,544 direct yes 2.1179 4.3883 4.7442 4 0.0 1

MACHIELS ALEC - Director

2021-08-17 16:42:44 -0400 2021-08-16 M 2,500 $2.67 a 672,044 direct yes 2.1179 4.3883 4.7442 4 0.0 1

MACHIELS ALEC - Director

2021-08-17 16:42:44 -0400 2021-08-16 M 2,500 d 137,529 direct yes

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-08-03 16:26:25 -0400 2021-08-02 S 250 $63.99 d 62,930 direct yes 1.7157 -8.7045 -46.482 4.5018 18 -49.2838 28

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-08-03 16:23:59 -0400 2021-08-02 S 1,000 $63.99 d 4,847 direct yes 1.7157 -8.7045 -46.482 4.5018 18 -49.2838 28

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-08-03 16:23:59 -0400 2021-08-02 M 1,000 $3.76 a 5,847 direct yes 1.7157 -8.7045 -46.482 4.5018 18 -49.2838 28

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-08-03 16:23:59 -0400 2021-08-02 M 1,000 d 6,161 direct yes

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 22:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 21:45:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 21:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 20:45:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 20:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 19:45:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 19:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 18:45:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 18:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 17:45:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 17:15:03 UTC -0.3598 0.4298 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 16:45:03 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 16:15:03 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 15:45:03 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 15:15:04 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 14:45:02 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 14:15:02 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 13:45:02 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 13:15:03 UTC -0.18 0.25 1800000
APELLIS PHARMACEUTICALS INC APLS 2021-09-24 12:45:03 UTC -0.18 0.25 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Market Neutral Fund APLS -2152.0 shares, $-66346.16 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund APLS -192.0 shares, $-5792.64 2020-09-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund APLS -6484.0 shares, $-328544.28 2021-04-30 N-PORT
Alger Funds II- Alger Dynamic Opportunities Fund APLS -34237.0 shares, $-1734788.79 2021-04-30 N-PORT
Guidestone Funds- Strategic Alternatives Fund APLS -3508.0 shares, $-221705.6 2021-06-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund APLS -7351.0 shares, $-464583.2 2021-06-30 N-PORT

Elevate your investments